MENUNews Archive
Date: 07/20/2012
Blocking IL-6 improved response to breast cancer drug Herceptin, U-M study finds
Written by Nicole Fawcett
Date: 07/17/2012
Written by: Kara Gavin; contact by telephone: 734-764-2220; or [email protected]
Date: 07/16/2012
A new study lead by University of Michigan Rogel Cancer Center researchers, led by lead author Bradley Zebrack, Ph.D., MSW, MPH; shows significant proportions of adolescents and young adult cancer patients are not getting their care needs met.
Date: 07/10/2012
UMSkinCheck tracks skin changes, offers skin check reminders.
Date: 06/20/2012
The information on this page has expired. Learn more about pancreatic cancer treatment and research on our pancreatic cancer webpages.
Date: 06/13/2012
Reshma Jagsi, M.D., D.Phil., associate professor at the University of Michigan Medical School, was lead author of the study that found, after taking specialty, productivity and other factors into consideration, gender disparity still exists among doctors.
Date: 06/05/2012
Over men 1200 men with metastatic, hormone-sensitive prostate cancer were given intermittent androgen-deprivation (AD) therapy after seven months of androgen deprivation. The results show intermittent hormone therapy offers some quality-of-life benefits, but lower overall survival.
Date: 06/04/2012
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59% of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Date: 05/22/2012
Initial results from a first-of-its-kind international consortium of adrenal cancer researchers suggest there might be a treatment standard for patients with adrenal cancer, an extremely rare and deadly disease.